Alpha Healthcare Acquisition Corp III 

$9.80
7
+$0.01+0.1% Friday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
155.9M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

10NovExpected
Q4 2020
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.02
0
0.02
0.04
Expected EPS
N/A
Actual EPS
0.04

Financials

-Profit Margin
Profitable
2021
2022
0Revenue
444,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.77B
Medtronic is a major player in the medical devices sector, directly competing with Carmell in the development and manufacturing of innovative biomedical products.
Stryker
SYK
Mkt Cap126.84B
Stryker specializes in medical technologies, including orthopedic products, which overlap with Carmell's focus on bone healing technologies.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare market, directly relevant to Carmell's bone and tissue healing products.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation offers medical solutions that compete with Carmell's products in the areas of pain management and rehabilitation.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical devices segment, competes across a broad range of healthcare products, including those for surgical and orthopedic use.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories provides a wide range of medical devices and healthcare solutions that compete with Carmell's offerings in the biomedical sector.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, Inc. develops and manufactures advanced surgical systems that could be seen as alternative solutions to Carmell's regenerative products.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences specializes in heart and vascular health technologies, competing indirectly by offering alternative medical treatments.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. provides a broad array of medical devices and pharmaceuticals that compete in the overall healthcare market, including areas covered by Carmell.

About

LONGEVITY HEALTH HLDGS
Show more...
CEO
Janakiram Ajjarapu
Employees
10
Country
United States
ISIN
US02073F1049

Listings

0 Comments

Share your thoughts

FAQ

What is Alpha Healthcare Acquisition Corp III stock price today?
The current price of ALPA is $9.80 USD — it has increased by +0.1% in the past 24 hours. Watch Alpha Healthcare Acquisition Corp III stock price performance more closely on the chart.
What is Alpha Healthcare Acquisition Corp III stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Alpha Healthcare Acquisition Corp III stocks are traded under the ticker ALPA.
What is Alpha Healthcare Acquisition Corp III market cap?
Today Alpha Healthcare Acquisition Corp III has the market capitalization of 155.9M
What were Alpha Healthcare Acquisition Corp III earnings last quarter?
ALPA earnings for the last quarter are 0.04 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Alpha Healthcare Acquisition Corp III revenue for the last year?
Alpha Healthcare Acquisition Corp III revenue for the last year amounts to 0 USD.
What is Alpha Healthcare Acquisition Corp III net income for the last year?
ALPA net income for the last year is 444,000 USD.
How many employees does Alpha Healthcare Acquisition Corp III have?
As of September 04, 2026, the company has 10 employees.
In which sector is Alpha Healthcare Acquisition Corp III located?
Alpha Healthcare Acquisition Corp III operates in the Health & Wellness sector.
When did Alpha Healthcare Acquisition Corp III complete a stock split?
Alpha Healthcare Acquisition Corp III has not had any recent stock splits.
Where is Alpha Healthcare Acquisition Corp III headquartered?
Alpha Healthcare Acquisition Corp III is headquartered in Pittsburgh, United States.